Skip to main content
. Author manuscript; available in PMC: 2013 May 1.
Published in final edited form as: Cancer. 2010 Nov 29;117(9):1917–1927. doi: 10.1002/cncr.25691

Figure 4.

Figure 4

(A) Kaplan-Meier plot displays the cumulative proportion of patients who experienced 1 or more episodes of febrile neutropenia over time in days after chemotherapy initiation for both high-risk and low-risk patients in the derivation population based on the risk model. (B) Kaplan-Meier plot displays the cumulative proportion of patients who experienced 1 or more episodes of febrile neutropenia over time in days after chemotherapy initiation for both high-risk and low-risk patients in the validation population based on the risk model.